These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31220100)

  • 21. Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy.
    Momose M; Kobayashi H; Iguchi N; Matsuda N; Sakomura Y; Kasanuki H; Kusakabe K; Okawa T
    Nucl Med Commun; 1999 Jun; 20(6):529-35. PubMed ID: 10451865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of performing 123I-metaiodobenzylguanidine myocardial scintigraphy at different times for the long-term prediction of cardiac events in patients with dilated cardiomyopathy.
    Nakanishi R; Fujimoto S; Utanohara Y; Takamura K; Inoue A; Yamashina S; Namiki A; Yamazaki J
    Nucl Med Commun; 2010 Jun; 31(6):488-94. PubMed ID: 20429093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
    Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group.
    Alba AC; Gaztañaga J; Foroutan F; Thavendiranathan P; Merlo M; Alonso-Rodriguez D; Vallejo-García V; Vidal-Perez R; Corros-Vicente C; Barreiro-Pérez M; Pazos-López P; Perez-David E; Dykstra S; Flewitt J; Pérez-Rivera JÁ; Vazquez-Caamaño M; Katz SD; Sinagra G; Køber L; Poole J; Ross H; Farkouh ME; White JA
    Circ Cardiovasc Imaging; 2020 Apr; 13(4):e010105. PubMed ID: 32312112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy.
    Raafs AG; Vos JL; Henkens MTHM; Slurink BO; Verdonschot JAJ; Bossers D; Roes K; Gerretsen S; Knackstedt C; Hazebroek MR; Nijveldt R; Heymans SRB
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1015-1026. PubMed ID: 35680209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy.
    Rubiś PP; Dziewięcka EM; Banyś P; Urbańczyk-Zawadzka M; Krupiński M; Mielnik M; Łach J; Ząbek A; Wiśniowska-Śmiałek S; Podolec P; Karabinowska A; Holcman K; Garlitski AC
    Sci Rep; 2021 Dec; 11(1):24000. PubMed ID: 34907272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging.
    Becker MAJ; van der Lingen ACJ; Wubben M; van de Ven PM; van Rossum AC; Cornel JH; Allaart CP; Germans T
    ESC Heart Fail; 2021 Apr; 8(2):1055-1063. PubMed ID: 33560582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
    Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
    Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.
    Murata K; Kusachi S; Murakami T; Nogami K; Murakami M; Hirohata S; Tominaga Y; Komatsubara I; Tsuji T
    Clin Cardiol; 1997 Jan; 20(1):61-6. PubMed ID: 8994740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
    Imamura Y; Fukuyama T
    Ann Nucl Med; 2002 Sep; 16(6):387-93. PubMed ID: 12416577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias.
    Torri F; Czimbalmos C; Bertagnolli L; Oebel S; Bollmann A; Paetsch I; Jahnke C; Arya A; Merkely B; Hindricks G; Dinov B
    Europace; 2019 Sep; 21(9):1392-1399. PubMed ID: 31102521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.